Today, the SVP Corp of Henry Schein (HSIC), Michael Ettinger, sold shares of HSIC for $626.4K.
In addition to Michael Ettinger, 2 other HSIC executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Henry Schein’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $3.28 billion and quarterly net profit of $121 million. In comparison, last year the company earned revenue of $3.16 billion and had a net profit of $138 million. HSIC’s market cap is $12.91B and the company has a P/E ratio of 33.06. Currently, Henry Schein has an average volume of 1.84M.
Based on 9 analyst ratings, the analyst consensus is Hold with an average price target of $85.71, reflecting a 0.7% upside.
The insider sentiment on Henry Schein has been negative according to 55 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.
